Zoledronic acid in metastatic castrate-sensitive prostate cancer: A state-of-the-art review

Prostate cancer is the most common cancer in men in developed countries. Despite its slow growing pattern, metastatic disease to bone occurs and results in a significant number of deaths. Since more than eight decades, the classical androgen deprivation therapy (ADT) leads to clinical response in mo...

Full description

Bibliographic Details

Published in:	Journal of Bone Oncology
Main Authors:	Nahed Damaj, Tala Najdi, Samah Seif, Nicolas Nakouzi, Joseph kattan
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Subjects:	Metastatic castrate sensitive prostate cancer Bisphosphonates Zoledronic acid Bone fracture Bone metastasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2212137425000089